SPAC Merger To Take SL Bio Public Through New Entity In 2026
SL Bio files Form F-4 with SEC to merge with Horizon Space Acquisition II Corp. Valued at $5.7B, SL Science Holding Limited will be listed as SLBT on NASDAQ. Alternative listing path for science-driven companies. Expected public listing in early 2026.